Main > ONCOLOGY (**) > GC/GEJ MET Adenocarcinoma> > CN. B. with High PD-L1 Expression

---

CN. B. with High PD-L1 Expression's subsections
(*) CN Approval Date: 2023. 02.24
>PD-1 Inhibitor+Fluoropyrimidine+Pt
Company
Generic Name
Patent>CN Patent Numbers
Patent>USA Patent Number
Web-Site

CN. B. with High PD-L1 Expression's products
This section has no products